PT  - JOURNAL ARTICLE
AU  - Carlos Antonio  Mouraa
AU  - Ana Luísa Cerqueira de Sant’Ana Costa
TI  - SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets – What to learn from Rheumatologists?
AID  - 10.3899/jrheum.200657
DP  - 2020 May 25
TA  - The Journal of Rheumatology
PG  - jrheum.200657
4099  - http://www.jrheum.org/content/early/2020/05/20/jrheum.200657.short
4100  - http://www.jrheum.org/content/early/2020/05/20/jrheum.200657.full
AB  - It was with great interest that we read the letter from Randy Cron and collaborators (1) linking the cytokine storm syndrome (CSS) seen in macrophage activation syndrome, common in the rheumatological setting, with the CSS postulated to be a background in the novel coronavirus (SARS-CoV-2) infection. Amid the high contagiousness of the virus, science was also infected by an infodemia, compelled to enter a race to find effective therapies studying mechanisms molecular aspects of SARS-CoV-2 concomitant to urgent bedside manage of patients.